Skip to Main Content

Paper Details

The Cytochrome P450 Slow Metabolizers CYP2C9*2 and CYP2C9*3 Directly Regulate Tumorigenesis via Reduced Epoxyeicosatrienoic Acid Production.
Cancer Res
21
2018
CYP2C*, CYP2C*1, CYP2C9, CYP2C9*, CYP2C9*1, CYP2C9*2, CYP2C9*3, CYPC29*, CYPC29*2, Cytochrome, Cytochrome P450, Cytochrome P450 variants, EET, EETs, Epoxyeicosatrienoic Acid, NADPH, NADPH-P450 reductase, NSCLC, NSCLC cells, arachidonic acid, cancer, cytochrome P450 CYP2C9, endothelial cells, epoxyeicosatrienoic acids, human, human CYP2C9 genes, mice, non-small cell lung cancer, tumors
Author NameAffiliation
Megan M ShueyVanderbilt University School of Medicine
Scott M WilliamsCase Western Reserve University
Scott M WilliamsCase Western Reserve University
  • 1 - 3

Datasets

Release 1.2